Skip to main content
Clinical Trials/NCT05760118
NCT05760118
Not yet recruiting
Not Applicable

Awareness of Osteoporosis in Diabetes Mellitus Patients

Uskudar State Hospital0 sites400 target enrollmentJuly 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus
Sponsor
Uskudar State Hospital
Enrollment
400
Primary Endpoint
Revised Osteoporosis Knowledge Test
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

Osteoporosis is a condition that describes compromised skeletal microarchitecture in general, with clinical signs of decreased bone mineral density. Diabetes mellitus patients are at increased risk for developing osteoporosis. Identifying whether multiple sclerosis patients have information and awareness about this disease is crucial. This study is aimed to investigate awareness and knowledge of osteoporosis in diabetes mellitus patients.

Detailed Description

Osteoporosis is a common disease of bone loss. The reduced bone strength predisposes an increased risk for fractures in older individuals. It can affect people from different ethnicity. Many factors increase the risk of osteoporosis, including age, postmenopausal state, glucocorticoid use, low body weight, calcium, vitamin D, immobility, and chronic inflammation. Patients with multiple sclerosis are at high risk of developing osteoporosis due to chronic inflammation and their medications. Patients' knowledge and awareness about osteoporosis are essential for early detection, implementation of lifestyle changes, and treatment compliance. This study aimed to investigate osteoporosis awareness and knowledge about osteoporosis in patients with diabetes mellitus.

Registry
clinicaltrials.gov
Start Date
July 1, 2023
End Date
March 1, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Uskudar State Hospital
Responsible Party
Principal Investigator
Principal Investigator

Mustafa Hüseyin Temel

Principal Investigator

Uskudar State Hospital

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of diabetes mellitus
  • Must be between the ages of 18 and 99
  • Must give consent to participate in the study

Exclusion Criteria

  • Not giving consent

Outcomes

Primary Outcomes

Revised Osteoporosis Knowledge Test

Time Frame: 1 day

The 32-item Revised Osteoporosis Knowledge Test (ROKT; 2012), as reported by Gendler et al. (2015), is a revision of the original 24-item OKT developed by Kim, Horan, \& Gendler (1991). This measure was developed to assess the osteoporosis knowledge of adults. Changes were made to update the original OKT to include current recommendations for calcium and vitamin D, exercise requirements, diagnosis and treatment, and a more comprehensive understanding of bone development and osteoporosis risk factors. It contains two subscales (Nutrition and Exercise), which share 14 common items including risk factors and general knowledge. Although the responses offered to participants are multiple choice (e.g., for risk items: more likely, less likely, neutral, don't know), there is only one correct answer for each item. Responses are dichotomously recoded as correct or incorrect.

Secondary Outcomes

  • Osteoporosis Self-Efficacy Scale(1 day)
  • Osteoporosis Health Belief Scale(1 day)

Similar Trials